Cargando…

Structural insight into mutations at 155 position of valosin containing protein (VCP) linked to inclusion body myopathy with Paget disease of bone and frontotemporal Dementia

Mutations in Valosin-containing protein (VCP) have been implicated in the pathology linked to inclusion body myopathy, paget disease of bone and frontotemporal dementia (IBMPFD). VCP is an essential component of AAA-ATPase superfamily involved in various cellular functions. Advanced In-silico analys...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Rui, Wei, Zhijie, Zhang, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071901/ https://www.ncbi.nlm.nih.gov/pubmed/33911929 http://dx.doi.org/10.1016/j.sjbs.2021.02.048

Ejemplares similares

Anti–Valosin‐Containing Protein (VCP/p97) Autoantibodies in Inclusion Body Myositis and Other Inflammatory Myopathies
por: Amlani, Adam, et al.
Publicado: (2022)

Psychiatric Presentation of Frontotemporal Dementia Associated with Inclusion Body Myopathy due to the VCP Mutation (R155H) in a French Family
por: Jacquin, Agnès, et al.
Publicado: (2013)

Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease
por: Ju, Jeong-Sun, et al.
Publicado: (2009)

Heterozygous mutations in valosin-containing protein (VCP) and resistance to VCP inhibitors
por: Bastola, Prabhakar, et al.
Publicado: (2019)

Valosin Containing Protein (VCP): A Multistep Regulator of Autophagy
por: Ferrari, Veronica, et al.
Publicado: (2022)

Lysine Methylation of the Valosin-Containing Protein (VCP) Is Dispensable for Development and Survival of Mice
por: Fusser, Markus, et al.
Publicado: (2015)

VCP Associated Inclusion Body Myopathy and Paget Disease of Bone Knock-In Mouse Model Exhibits Tissue Pathology Typical of Human Disease
por: Badadani, Mallikarjun, et al.
Publicado: (2010)

Valosin-Containing Protein (VCP/p97) Is an Activator of Wild-Type Ataxin-3
por: Laço, Mário N., et al.
Publicado: (2012)

Valosin containing protein (VCP): initiator, modifier, and potential drug target for neurodegenerative diseases
por: Chu, Siwei, et al.
Publicado: (2023)

Loss of the novel Vcp (valosin containing protein) interactor Washc4 interferes with autophagy-mediated proteostasis in striated muscle and leads to myopathy in vivo
por: Kustermann, Monika, et al.
Publicado: (2018)

Valosin-containing protein (VCP/p97) inhibitors relieve Mitofusin-dependent mitochondrial defects due to VCP disease mutants
por: Zhang, Ting, et al.
Publicado: (2017)

Valosin-Containing Protein (VCP)/p97: A Prognostic Biomarker and Therapeutic Target in Cancer †
por: Costantini, Susan, et al.
Publicado: (2021)

A Determination of p97/VCP (Valosin Containing Protein) and SVIP (Small VCP Interacting Protein) Expression Patterns in Human Testis
por: Arıcı, Akgül, et al.
Publicado: (2023)

The AAA + ATPase valosin-containing protein (VCP)/p97/Cdc48 interaction network in Leishmania
por: Aguiar, Bruno Guedes, et al.
Publicado: (2020)

Valosin-containing protein (VCP/p97) plays a role in the replication of West Nile virus
por: Phongphaew, Wallaya, et al.
Publicado: (2017)

Valosin-containing protein Asp395Gly mutation in a patient with frontotemporal dementia: a case report
por: Kobayashi, Ryota, et al.
Publicado: (2022)

VCP/p97 inhibitor CB-5083 modulates muscle pathology in a mouse model of VCP inclusion body myopathy
por: Cheng, Cheng, et al.
Publicado: (2022)

Pharmacological targeting of valosin containing protein (VCP) induces DNA damage and selectively kills canine lymphoma cells
por: Nadeau, Marie-Ève, et al.
Publicado: (2015)

Developmental expression of p97/VCP (Valosin-containing protein) and Jab1/CSN5 in the rat testis and epididymis
por: Cayli, Sevil, et al.
Publicado: (2011)

Valosin-containing protein (VCP) promotes the growth, invasion, and metastasis of colorectal cancer through activation of STAT3 signaling
por: Fu, Qianfeng, et al.
Publicado: (2016)

Upregulation of valosin-containing protein (VCP) is associated with poor prognosis and promotes tumor progression of orbital B-cell lymphoma
por: Zhu, Wenwen, et al.
Publicado: (2018)

Valosin-containing protein (VCP/p97) inhibition reduces viral clearance and induces toxicity associated with muscular damage
por: del Rio Oliva, Marta, et al.
Publicado: (2022)

The Role of VCP Mutations in the Spectrum of Amyotrophic Lateral Sclerosis—Frontotemporal Dementia
por: Scarian, Eveljn, et al.
Publicado: (2022)

A Novel Mutation (D395A) in Valosin-Containing Protein Gene Is Associated With Early Onset Frontotemporal Dementia in an Italian Family
por: Bruno, Francesco, et al.
Publicado: (2021)

Valosin-Containing Protein (VCP/p97)-Expression Correlates with Prognosis of HPV- Negative Oropharyngeal Squamous Cell Carcinoma (OSCC)
por: Meyer, Moritz F., et al.
Publicado: (2014)

Mutations in valosin-containing protein (VCP) decrease ADP/ATP translocation across the mitochondrial membrane and impair energy metabolism in human neurons
por: Ludtmann, Marthe H. R., et al.
Publicado: (2017)

Case report: Frontotemporal dementia and amyotrophic lateral sclerosis caused by a missense variant (p.Arg89Trp) in the valosin-containing protein gene
por: Miura, Shiroh, et al.
Publicado: (2023)

The Homozygote VCP(R155H/R155H) Mouse Model Exhibits Accelerated Human VCP-Associated Disease Pathology
por: Nalbandian, Angèle, et al.
Publicado: (2012)

A Sensitive Yellow Fever Virus Entry Reporter Identifies Valosin-Containing Protein (VCP/p97) as an Essential Host Factor for Flavivirus Uncoating
por: Ramanathan, Harish N., et al.
Publicado: (2020)

CRISPR/Cas9-Mediated Constitutive Loss of VCP (Valosin-Containing Protein) Impairs Proteostasis and Leads to Defective Striated Muscle Structure and Function In Vivo
por: Voisard, Philipp, et al.
Publicado: (2022)

Prevalence of Frontotemporal Dementia in Females of 5 Hispanic Families With R159H VCP Multisystem Proteinopathy
por: Shmara, Alyaa, et al.
Publicado: (2023)

Skeletal muscle cell protein dysregulation highlights the pathogenesis mechanism of myopathy-associated p97/VCP R155H mutations
por: Luzzi, Anna, et al.
Publicado: (2023)

Spastic Paraplegia with Paget's Disease of Bone due to a VCP Gene Mutation
por: Nakamura, Takumi, et al.
Publicado: (2020)

The Cure VCP Scientific Conference 2021: Molecular and clinical insights into neurodegeneration and myopathy linked to multisystem proteinopathy-1 (MSP-1)
por: Johnson, Michelle A., et al.
Publicado: (2022)

Insights into Muscle Degeneration from Heritable Inclusion Body Myopathies
por: Krause, Sabine
Publicado: (2015)

MON-LB70 The Association of Paget’s Disease With Inclusion Body Myositis and Fronto Temporal Dementia (IBMFTD)
por: Miller, Clare, et al.
Publicado: (2020)

VCP-related myopathy: a case series and a review of literature
por: Iannibelli, Eliana, et al.
Publicado: (2023)

Provisional practice recommendation for the management of myopathy in VCP‐associated multisystem proteinopathy
por: Roy, Bhaskar, et al.
Publicado: (2023)

An Integrated In Silico, In Vitro and Tumor Tissues Study Identified Selenoprotein S (SELENOS) and Valosin-Containing Protein (VCP/p97) as Novel Potential Associated Prognostic Biomarkers in Triple Negative Breast Cancer
por: Costantini, Susan, et al.
Publicado: (2022)

Rare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositis
por: Gang, Qiang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nai2tponrbsek1nfnb660m1lrj